WP
EPIX

Woodline Partners’s ESSA Pharma EPIX Stock Holding History

Woodline Partners’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-382,282
Closed -$696K – 788
2022
Q3 		$696K Buy
+382,282
New +$1.01M 0.01% 566
2022
Q2 		– Sell
-375,084
Closed -$2.32M – 822
2022
Q1 		$2.32M Sell
375,084
-309,163
-45% -$2.72M 0.04% 363
2021
Q4 		$9.72M Buy
684,247
+507,239
+287% +$5.65M 0.14% 203
2021
Q3 		$1.42M Buy
+177,008
New +$2.81M 0.02% 471

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Woodline Partners's EPIX Position: Q4 2022 in Review

Woodline Partners sold out of ESSA Pharma (EPIX) in Q4 2022, closing a stake of 382,282 shares — an estimated $696K sold.

Woodline Partners first reported a position in EPIX in Q3 2021 and held it in 4 quarters. The position peaked at $9.72M in Q4 2021. 45 funds tracked by Wall St. Rank hold EPIX as of Q4 2022.

  • Woodline Partners reported no remaining ESSA Pharma position as of Q4 2022 after selling out during the quarter.
  • Woodline Partners sold 382,282 ESSA Pharma shares in Q4 2022, an estimated $696K.
  • Woodline Partners first reported a position in ESSA Pharma in Q3 2021 and held it in 4 quarters.
  • Woodline Partners's ESSA Pharma position peaked at $9.72M in Q4 2021.
  • 45 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2022.

Based on Woodline Partners's 13F filing for Q4 2022, filed 14 Feb 2023.